MMS May Help Men With Rare Penile Cancer
According to an article published in UroToday, a tissue sparing procedure called Moh’s Micrographic Surgery, or MMS, may help men with certain forms of penile cancer.
MMS, already a proven therapy for some skin cancers, involves intra-operative microscopic examination of sectioned tissue by a specially trained dermatologic surgeon. The surgery maximizes the amount of normal penis tissue preserved while eradicating the malignant tumor, but the method is time intensive and requires close follow-up by an experienced urologist.
Serious complications such as meatal stenosis can occur and the recurrence rate is relatively high, however, long term progression and survival rates were close to those found in patients treated with more aggressive surgical interventions.
Penile cancer is relatively rare in the United States, but it is often lethal because men with the disease frequently refuse conventional treatment methods that require a partial or total penectomy.
The procedure is not recommended for all forms of penile cancer, but it may provide a way for some patients to treat the disease without undergoing the psychological effects associated with penis removal.
Source: UroToday.com
Related Links: Oregon Health and Science University; American Society for Mohs Surgery
Related Podcast: Vaccines: Guidelines for Healthcare Providers – HPV from the Centers for Disease Control and Prevention
Tags: squamous cell carcinoma; urology; urethra; genitourinary
Print This
|
| Sphere: Related Content
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URI
Leave a comment
Browse All Categories: Next article: FDA Issues New Warnings About Anti-Anemia Drugs
Previous article: Mass Spectrometry Made Easier By Scripps
